Australia TGA ARTG record

Medicine administration kit, percutaneous, medicated, single-use

Australia TGA ARTG Registered Device · Abbvie Pty Ltd · Abbvie Inc · Class I · Started August 09, 2019

Good Name: Abbvie Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use

Device classification

Risk Class: Class I
Product Type: Procedure Pack
ARTG Category: General

Registration information

Start Date: August 09, 2019
Effective Date: August 09, 2019

Sponsor

Name: Abbvie Pty Ltd

Manufacturer

Name: Abbvie Inc
Country: United States of America
Address: 1 North Waukegan Road, North Chicago, IL, 60064

Intended purpose

Skyrizi procedure pack containing a pre-filled syringe containing risankizumab solution for injection and a cleansing alcohol swab.

About this record

Access comprehensive regulatory information for Medicine administration kit, percutaneous, medicated, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Abbvie Pty Ltd, manufactured by Abbvie Inc in United States of America. The device registration started on August 09, 2019.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.